AT353415B - Verfahren zur herstellung eines pharma- zeutischen praeparates - Google Patents

Verfahren zur herstellung eines pharma- zeutischen praeparates

Info

Publication number
AT353415B
AT353415B AT192276A AT192276A AT353415B AT 353415 B AT353415 B AT 353415B AT 192276 A AT192276 A AT 192276A AT 192276 A AT192276 A AT 192276A AT 353415 B AT353415 B AT 353415B
Authority
AT
Austria
Prior art keywords
manufacturing
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
AT192276A
Other languages
German (de)
English (en)
Other versions
ATA192276A (de
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of ATA192276A publication Critical patent/ATA192276A/de
Application granted granted Critical
Publication of AT353415B publication Critical patent/AT353415B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT192276A 1975-03-17 1976-03-16 Verfahren zur herstellung eines pharma- zeutischen praeparates AT353415B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (2)

Publication Number Publication Date
ATA192276A ATA192276A (de) 1979-04-15
AT353415B true AT353415B (de) 1979-11-12

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT192276A AT353415B (de) 1975-03-17 1976-03-16 Verfahren zur herstellung eines pharma- zeutischen praeparates

Country Status (21)

Country Link
JP (1) JPS51115910A (nl)
AR (1) AR222624A1 (nl)
AT (1) AT353415B (nl)
AU (1) AU505355B2 (nl)
CA (1) CA1073358A (nl)
CH (1) CH630257A5 (nl)
DD (1) DD124102A5 (nl)
DE (1) DE2611041A1 (nl)
DK (1) DK148344C (nl)
ES (1) ES446075A1 (nl)
FR (1) FR2304354A1 (nl)
GB (1) GB1546448A (nl)
GR (1) GR60341B (nl)
IE (1) IE43083B1 (nl)
LU (1) LU74558A1 (nl)
MC (1) MC1101A1 (nl)
NL (1) NL190313C (nl)
NZ (1) NZ180321A (nl)
PH (1) PH14927A (nl)
PT (1) PT64907B (nl)
SE (1) SE433804B (nl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DE69207656T2 (de) * 1991-01-30 1996-10-17 Wellcome Found Wasserlösliche tabletten
DE69226950T2 (de) * 1991-04-08 1999-05-12 Nippon Shinyaku Co Ltd Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt
CA2132012C (en) * 1992-03-25 2003-04-22 John W. Shell Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
CA2175225C (en) * 1993-10-29 2004-09-21 Keith Graeme Hutchison Gelatin capsule fill able to foam
WO1995011668A1 (en) * 1993-10-29 1995-05-04 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
JPH10500412A (ja) * 1994-05-13 1998-01-13 スミスクライン・ビーチャム・コーポレイション カルシウム摂取を増加させるための方法および組成物
JPH10509981A (ja) * 1994-12-01 1998-09-29 サイバス ファーマシューティカル,インコーポレイティド 高等植物から得られうる粉末状親水コロイドゴムを用いる持効性薬剤送出
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (nl) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
GR60341B (en) 1978-05-17
GB1546448A (en) 1979-05-23
DE2611041A1 (de) 1976-10-14
PT64907B (fr) 1978-03-24
CA1073358A (en) 1980-03-11
MC1101A1 (fr) 1977-02-04
ATA192276A (de) 1979-04-15
AU1204976A (en) 1977-09-22
AR222624A1 (es) 1981-06-15
IE43083B1 (en) 1980-12-17
NL190313B (nl) 1993-08-16
LU74558A1 (nl) 1977-09-27
DK113676A (da) 1976-09-18
PH14927A (en) 1982-01-29
CH630257A5 (en) 1982-06-15
AU505355B2 (en) 1979-11-15
DD124102A5 (nl) 1977-02-02
NL190313C (nl) 1994-01-17
IE43083L (en) 1976-09-17
DK148344C (da) 1985-11-04
SE7603325L (sv) 1976-09-18
ES446075A1 (es) 1977-09-16
SE433804B (sv) 1984-06-18
JPS51115910A (en) 1976-10-13
FR2304354B1 (nl) 1979-04-27
FR2304354A1 (fr) 1976-10-15
NZ180321A (en) 1978-06-20
PT64907A (fr) 1976-04-01
JPS638084B2 (nl) 1988-02-19
DK148344B (da) 1985-06-17
NL7602776A (nl) 1976-09-21
DE2611041C2 (nl) 1988-06-09

Similar Documents

Publication Publication Date Title
AT353415B (de) Verfahren zur herstellung eines pharma- zeutischen praeparates
AT347038B (de) Verfahren zur herstellung eines diaetpraeparats
AT348845B (de) Verfahren zur herstellung eines u-foermigen koerpers
ATA598975A (de) Verfahren zur herstellung eines praparates zur behandlung interferonsensibler infektionskrankheiten
AT347578B (de) Verfahren zur herstellung einer neuen arzneimittelzubereitung
ATA713376A (de) Verfahren zur herstellung eines rektal anwendbaren pharmazeutischen praparates
AT330954B (de) Verfahren zur herstellung eines pharmazeutischen praparates
DD131019A5 (de) Verfahren zur herstellung eines 2-desoxystreptaminaminoglycosides
ATA939874A (de) Bindepechs eines verfahren zur herstellung
ATA209076A (de) Verfahren zur herstellung einer topischen zubereitung
ATA885874A (de) Verfahren zur herstellung eines schwammartigen keramischen korpers
AT339253B (de) Verfahren zur herstellung eines reinen ceroxids
AT353543B (de) Verfahren zur herstellung eines nagetierbe- kaempfungsmittels
CH620563B (de) Verfahren zur herstellung eines zifferblattes.
AT330962B (de) Verfahren zur herstellung eines praparates zur nasalen applikation
AT338515B (de) Verfahren zur herstellung eines katalysators
AT329743B (de) Verfahren zur herstellung eines praparates zur nasalen applikation
AT350436B (de) Verfahren zur herstellung eines schuhes
AT338415B (de) Verfahren zur herstellung eines lipasereichen enzympraparates
AT347316B (de) Verfahren zur herstellung eines kapsel- empfindlichen gelierten sprengstoffes
AT352841B (de) Verfahren zur herstellung eines filmbildenden bindemittels
AT352658B (de) Verfahren zur herstellung eines trennbaren reissverschlusses
PT65800B (de) Verfahren zur herstellung einer pharmazeutischen zubereitung
ATA346574A (de) Verfahren zur herstellung eines hohlbausteines
AT337454B (de) Verfahren zur herstellung eines latex

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties